Rovin Capital UT ADV Purchases Shares of 2,243 Danaher Corporation (NYSE:DHR)

Rovin Capital UT ADV acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 2,243 shares of the conglomerate's stock, valued at approximately $460,000.

A number of other institutional investors have also recently bought and sold shares of DHR. Norges Bank purchased a new stake in shares of Danaher during the fourth quarter worth about $2,130,740,000. GAMMA Investing LLC lifted its stake in Danaher by 24,958.2% during the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after purchasing an additional 1,863,381 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Danaher during the 4th quarter valued at about $391,172,000. Two Sigma Advisers LP grew its holdings in shares of Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after purchasing an additional 1,601,800 shares during the last quarter. Finally, Capital World Investors grew its stake in Danaher by 32.7% during the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after buying an additional 1,566,658 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president directly owned 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Leerink Partners boosted their price target on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday. Deutsche Bank Aktiengesellschaft reduced their target price on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Robert W. Baird reduced their price target on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $248.61.

Danaher Stock Up 1.8%

Danaher stock traded up $3.46 during mid-day trading on Tuesday, hitting $201.00. 3,976,045 shares of the company's stock were exchanged, compared to its average volume of 3,511,527. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The stock has a 50 day moving average of $195.09 and a two-hundred day moving average of $207.89. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market cap of $143.85 billion, a P/E ratio of 39.03, a P/E/G ratio of 2.79 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.64%. Danaher's dividend payout ratio is 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.